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1 Introduction 
Distinct mouse bone marrow macrophage 
precursors identified by differential expression of 
ER-MP12 and ER-MP20 antigens 
The characterization of early branch points in the differentiation of leukocytes 
requires identification of precursor cells in the bone marrow. Recently, we 
produced two monoclonal antibodies, ER-MP12 and ER-MP20, which in 
two-color flow-cytometric analysis divide the murine bone marrow into six 
defined subsets. Here we show, using fluorescence-activated cell sorting followed 
by macrophage colony-stimulating factor-stimulated culture in soft agar, that 
precursors of the mononuclear phagocyte system reside only within the 
ER-MP12hi20-, ER-MP12+20+ and ER-MP12-20hi bone marrow subsets. 
Together, these subsets comprise 15 % of nucleated bone marrow cells. Further- 
more, we provide evidence that the macrophage precursors present in these 
subsets represent successive stages in a maturation sequence where the most 
immature ER-MP12hi20- cells develop via the ER-MP12+20f stage into 
ER-MP12-20hi monocytes. 
Macrophages form a heterogeneous population of cells 
which play essential roles in a wide variety of biological 
processes (for reviews see [l, 21). As yet, it is not clear 
whether their extensive diversity is generated solely at the 
level of the monocytes entering the tissue microenviron- 
ments, or also at the level of the macrophage precursors in 
the bone marrow. Studies on the early stages of macro- 
phage development have been seriously hampered by the 
limited characterization and low frequency of macrophage 
precursors in the bone marrow. To approach this problem, 
we previously produced a panel of monoclonal antibodies 
(mAb) using immortalized macrophage precursors as 
immunogens [3]. Two of these mAb, ER-MP12 and ER- 
MP20, were shown to detect phenotypic heterogeneity 
among bone marrow macrophage precursors [3]. In the 
present study we aimed at identifying distinct macrophage 
precursor subsets in mouse bone marrow using ER-MP12 
and ER-MP20 mAb in two-color flow-cytometric analysis 
and cell sorting. Bone marrow subsets sorted on the basis of 
their differential expression of ER-MP12 and ER-MP20 
antigens were examined on cellular composition, macro- 
phage colony/cluster-forming capacity, cell surface expres- 
sion of the macrophage maturation-related marker Mac-1, 
and expression of ER-MP12 and ER-MP20 antigens during 
macrophage maturation in vitro. In this report we show that 
three phenotypically distinct subsets of M-CSF-responsive 
bone marrow macrophage precursors can be identified. 
Moreover, our data indicate that these three macrophage 
precursor subsets reflect successive, phenotypically 
defined, stages of in vivo macrophage development. 
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2 Materials and methods 
2.1 Mice 
Female C57BL/6-Ly-5. l - P e ~ ~ ~  mice (breeding pairs kindly 
provided by Dr. I. L. Weissman, Stanford University, 
Stanford, CA) between 6 and 20 weeks old were used in all 
experiments. Animals were kept under clean routine 
laboratory conditions with free access to food and water. 
2.2 Antibodies and conjugates 
The mAb used in this study were MU70 (anti-Mac-1 [4]), 
ER-BMDM1 (anti-aminopeptidase N [5]), ER-MP12 [3], 
and ER-MP20 (anti-Ly-6C [3]). Antibodies were applied as 
hybridoma culture supernatants or as purified mAb conju- 
gated to FITC (fluorescein isothiocyanate, isomer I, Sigma 
Chemical Co., St. Louis, MO) or biotin (N-hydroxysuccin- 
imidobiotin, Boehringer Mannheim GMBH, Mannheim, 
FRG) by standard procedures. 
R-Phycoerythrin-conjugated streptavidin (SAV-PE; Caltag 
Laboratories, CA), Tri-Color-conjugated streptavidin 
(SAV-TC; Caltag Laboratories), FITC-conjugated rabbit 
anti-rat IgG F(ab)2 fragments (RcrRa-FITC; Cappel, Orga- 
non Teknika, Turnhout, Belgium), and R-phycoerythrin- 
conjugated goat-anti-rat IgG (mouse-adsorbed; GcrRa-PE; 
Caltag Laboratories) ,were used as second stage fluorescent 
reagents. 
2.3 Preparation of cell suspensions 
Bone marrow cell suspensions were prepared as described 
previously [6]. Briefly, femora and tibiae were ground, 
using a mortar, in Dutton’s Balanced Salt Solution (Gibco, 
Breda,The Netherlands) supplemented with 5 % fetal calf 
serum, 60 pg/ml penicillin and 100 pg/ml streptomycin 
(DBSS-FCS-PS). The cell suspension was aspirated 
through a 22-gauge needle and filtered over a nylon sieve 
(mesh size 100 pm; Polymon PES, Kabel, Amsterdam,The 
Netherlands) to remove connective tissue, bone fragments, 
and clumps of cells. 
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Cultured bone marrow cells were isolated from Teflon bags 
(see below) and washed with DBSS-FCS-PS prior to 
immunofluorescence labeling. 
2.4 Immunofluorescence labeling, flow-cytometric 
analysis and cell sorting 
For phenotypic analyses, 1 x 106 - 5 x lo6 freshly isolated 
bone marrow cells/well or 5 x lo4 cultured cells/well were 
aliquotted into 96-microwell plates (round-bottom, Nunc, 
Denmark) and labeled with the appropriate antibodies in 
phosphate-buffered saline supplemented with 0.5 % 
bovine serum albumin and 20 mM NaN3 (PBS-BSA-NaN3). 
All incubations were performed on ice for 30 min and were 
followed by three washes with PBS-BSA-NaN3. For single- 
color analysis, cells were incubated first with hybridoma 
supernatant, washed and then incubated with RaRa-FITC, 
supplemented with 2% normal mouse serum (NMS) to 
avoid nonspecific binding. For two-color analysis, cells were 
incubated first with biotinylated mAb, followed by FITC- 
labeled mAb and SAV-PE simultaneously. For three-color 
analysis, cells were incubated first with hybridoma super- 
natant followed by GaRa-PE. After two washes, cells were 
washed in the presence of 3 % normal rat serum to block 
free binding sites on GaRa-PE. Subsequently, cells were 
incubated with biotinylated mAb followed by FITC- 
labeled mAb and SAV-TC simultaneously. Percentages of 
positive cells obtained from three-color analysis were 
compared with those obtained from single stainings and 
were found to be identical (data not shown). Culture 
supernatant of the nonproducing Y3 myeloma followed by 
RaRa-FITC (one-color analysis) or GaRa-PE (three-color 
analysis) was used as negative control, since, in our hands, 
control values obtained withY3 supernatant are identical to 
those obtained with rat isotype control mAb (unpublished 
data). Phenotypic analyses were performed with a FAC- 
Scan cytofluorimeter (Becton Dickinson, Sunnyvale, CA). 
For cell sorting experiments, 2 x lo8 bone marrow cells 
were incubated for 30 min with 2 ml DBSS-FCS-PS con- 
taining biotinylated ER-MP12, washed with a large volume 
of DBSS-FCS-PS and subsequently incubated (30 min) 
with 2 ml optimally diluted ER-MP20-FITC and SAV-PE 
simultaneously. After two washes, the cells were resus- 
pended in PBS supplemented with BSA (0.5% w/v), 
D-glucose (0.45 YO w/v; Merck, Amsterdam, The Nether- 
lands), penicillin (60 pg/ml) and streptomycin (100 pg/ml) 
to a final concentration of 3 x to6 cells/ml. Before sorting, 
the cell suspension was filtered over a 30-pm sieve (Poly- 
mon PES) to avoid clogging of the nozzle. All sorts were 
performed using a FACS Vantage cell sorter (Becton 
Dickinson). After sorting, viable cells were counted using a 
Burker hemocytometer. The purity of the sorted cell 
populations was determined by FACScan analysis and 
exceeded 95 % , unless stated otherwise. 
2.5 M-CSF-stimulated bone marrow culture 
The medium used for M-CSF-stimulated bone marrow 
culture (either in soft agar or in Teflon culture bags, see 
below) was a-modified DMEM (Gibco) supplemented with 
20% L cell-conditioned medium (LCM) as a source of 
M-CSF, 20 YO FCS (heat-inactivated; Hyclone Laborato- 
ries, UT), glutamine (2 mM), penicillin (60 pg/ml), strep- 
tomycin (100 pg/ml), P-mercaptoethanol M) and so- 
dium selenite M). LCM was prepared as previously 
described [7]. The same LCM and FCS batches were used 
throughout the study. 
To assess the frequency of macrophage precursors within 
the sorted subsets the macrophage colony- and cluster- 
forming capacity of the sorted cells was determined in 
M-CSF-stimulated culture in soft agar. Cloning was per- 
formed as described by Wijffels et al. [8] with minor 
modifications. Briefly, a 6 YO agar stock (Bacto-Agar, Difco 
Laboratories, Detroit, MI) was diluted with warm (42 "C) 
culture medium. Cells were plated in 0.5 ml 0.3 YO agar 
medium on top of a layer of 0.3 m10.5 YO agar medium in 
24-well plates (Costar, Cambridge, MA). Per sorted bone 
marrow subset two different cell concentrations were plated 
into six wells/concentration: 1000 and 250 cells/well for the 
ER-MP12med20-, ER-MP12-20-, ER-MP12-20med subsets 
and unlabeled, unseparated bone marrow, and 250 and 
100 cells/well for the ER-MP12hi20-, ER-MP12+20+, and 
ER-MP12-20hi subsets. After 12 to 14 days of culture 
(37"C, 7 %  CO2), the number of macrophage colonies 
(2 50 cells) and clusters (< 50 cells) generated from each 
subset was assessed by examining the plates using an 
inverted light microscope at low magnification. LCM as a 
source of M-CSF specifically stimulates macrophage devel- 
opment, as only macrophage progeny could be detected 
using morphological and immunohistological analysis (data 
not shown). 
For phenotypic analysis of in vitro matured mononuclear 
phagocytes, sorted cells were cultured inTeflon culture bags 
in M-CSF-containing medium [9]. Depending on the 
duration of culture, the initial cell number was adjusted to 
ensure optimal growth and viability. Thus, 2 x lo4 cells 
were seeded in a volume of 2 ml medium for phenotypic 
analysis at day 2 of culture, and lo4 cells, also in a volume of 
2 ml, for analysis after 5 and 7 days of culture. 
2.6 Morphological analysis 
Differential morphological analysis of sorted bone marrow 
subsets was performed on May-Grunwald-Giemsa stained 
cytospin preparations. Per subset 500 cells were ana- 
lyzed. 
3 Results 
3.1 ER-MPl2 and ER-MPU) mAb recognize 
morphologically distinct bone marrow subsets 
Using the anti-macrophage precursor mAb ER-MP12 and 
ER-MP20, six phenotypically distinct subsets can be 
detected in the bone marrow of the mouse [6]. Two subsets 
express the ER-MP12 antigen but not the ER-MP20 
antigen: an ER-MP12med20- and an ER-MP12hi20- subset 
(Fig. 1). Similarly, two subsets exclusively express the 
ER-MP20 antigen: an ER-MP12-20med and an ER- 
MP12-20hi subset. Of the remaining two subsets, one 
expresses both ER-MP12 and ER-MP20 antigens, i.e. 
ER-MP12+20+ (for this subset no distinction was made in 
levels of antigen expression), and one lacks both antigens, 
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%of cells in window: 
1. 1.7 4. 32.5 
2. 21.9 5. 31.0 
3. 8.4 6. 4.6 
ER-MPPO 
Figure 1 .  Two-color FACScan analysis of nucleated bone marrow 
cells labeled with ER-MP12 and ER-MP20 mAb. Percentages are 
the mean of eight experiments. 
i. e.  ER-MF'12-20-. In this study we determined the cellular 
composition of the six ER-MP12/20 bone marrow subsets. 
Therefore each subset was sorted, stained with May- 
Griinwald-Giemsa and differentially counted (Table 1 and 
Fig. 2). The smallest subset, ER-MP12fi20-, consisted 
predominantly of blast cells: morphologically undifferen- 
tiated blasts as well as recognizable blasts of the myeloid, 
erythroid and lymphoid lineages. The ER-MP12med20- 
subset was remarkably homogenous with predominantly 
mature lymphoid cells and a few undifferentiated blasts. 
The ER-MP12+20+ subset contained a large proportion of 
morphologically undifferentiated blasts, together with 
recognizable precursors of the myeloid, erythroid and 
lymphoid lineages. The ER-MP12-20- subset consisted 
almost exclusively of erythroid cells, erythroblasts as well as 
more mature cells. The ER-MP12-20med subset was highly 
enriched for granulocytes. Finally, the ER-MP12-20hi 
subset contained mainly monocytes and a few immature 
myeloid cells and undifferentiated blasts. Thus, on the basis 
of ER-MP12 and ER-MP20 antigen expression, mouse 
bone marrow can be separated into six morphologically 
distinct subsets with a relatively high cell type homogene- 
ity. 
Figure 2. May-Griinwald-Giemsa-stained cytocentrifuge prepara- 
tions of bone marrow subsets sorted on the basis of ER-MP12 and 
ER-MP20 expression. (a) ER-MP12hi20- bone marrow subset; (b) 
ER-MP12med20- subset; (c) ER-MP12+20+ subset; (d) ER- 
MP12-20- subset; (e) ER-MP12-20med subset; (f) ER-MP12-20hi 
subset. Magnification X 350. 
3.2 M-CSF-responsive macrophage precursors have the 
ER-MPUhiU)-, ER-MPl2+20+ or ER-MPl2-2W 
phenotype 
The morphological analysis of the sorted subsets showed 
that putative macrophage precursors, i.e. morphologically 
undifferentiated blasts, immature myeloid cells and mono- 
cytes, are mainly present in the ER-MP12hi20-, ER- 
MP12med20-, ER-MP12+20+, and ER-MP12-20hi subsets. 
To verify the presence of macrophage precursors in one or 
more of these subsets, and their absence from the other 
ER-MP12/20 subsets, all six bone marrow subsets were 
isolated by cell sorting and cloned in soft agar in the 
presence of the macrophage-specific growth factor M-CSF. 
Only from the ER-MP12hi20-, ER-MP12+20+ and ER- 
Table 1. Morphological analysis of the bone marrow subsets sorted on the basis of ER-MP12 and ER-MP20 antigen expressional 
Bone marrow Myeloid Erythroid Lymphoid Megakaryo- Undifferentiated 
subset cytic blasts 
Immature Band + Monocytes Erythroblast Polychrom + 
progenitors segmented normoblasts 
49 
45 
-ER-MP12hi20- 4b) 0 1 18 3 25 0 ER-MPl 2m"d20- 0 0 1 1 0 - 87 1 10 
ER-MP12+20+ 20 7 7 14 3 4 0 
ER-MP12-20- 0 0 0 15 - 76 0 0 9 
ER-MP12-20med 4 - 91 2 0 0 0 0 3 
ER-MP12-20hi 19 0 74 - 1 0 0 0 6 
a) The sorted bone marrow subsets were spun onto microscopic sIides and stained with May-Griinwald-Giernsa. Per subset 500 nucleated 
cells were examined. 
b) Data represent the percentage of cells present in the ER-MP12120 subsets. FACScan analysis of the sorted bone marrow subsets 
revealed that the purity of the sorted fractions varied between 87 % for the ER-MP12+20+ subset and > 95 % for the other subsets. In 
each subset the prevailing cell type is underlined. 
-
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Table 2. Presence of M-CSF-responsive macrophage precursors in bone marrow subsets sorted on the basis of ER-MP12 and ER-MP20 
antigen expressiona) 
M. F. T. R. de Bruijn, W. A. T. Slieker, J. C. M. van der Loo et al. 
Bone marrow subset No. of colonies/103 No. of clusters/l@ Mean frequency of macro- Mean no. of macrophage 
plated cellsh) plated cells phage precursors within precursors/104 NBMC 
subset (M-CFCIM-clustFC)C) 
ER-MP12hi20- 108 * 9 1 2 a  1 
ER-MP12+20+ 22 _+ 8 94 f 10 
ER-MP12-20hi O f 0  409 f 95 









Macrophage colonies and clusters were determined after 12-14 days of M-CSF-stimulated culture in soft agar. Colonies contain 
2 50 cells; clusters < 50 cells. No macrophage colonies or clusters were obtained from ER-MP12med20-, ER-MP12-20-, and 
ER-MP12-2Ped bone marrow subsets. 
Data are the mean -t SD of three experiments. For each subset, two different concentrations of sorted cells were plated. Per 
concentration the number of colonies and clusters per lo3 cells was calculated. The numbers shown in the table are the means of those 
calculated numbers.The numbers were corrected for the impurity of the sorted subsets; this was possible since contaminating cells were 
only from the subsets from which no macrophage colonies or clusters could be obtained. The means of the relative sizes of the bone 
marrow subsets in these three experiments were used to calculate the absolute numbers of macrophage precursors, and were 1.7 % for 
the ER-MP12hi20- subset, 7.9% for the ER-MP12+20+ subset and 4.6% for the ER-MP12-20hi subset. 
NBMC: Nucleated bone marrow cells M-clustFC: Macrophage cluster-forming cell. 
BM: Bone marrow. 
MP12-20hi subsets could macrophage colonies and clusters 
be grown (Table 2). No macrophage colonies or clusters 
were obtained from the other three subsets. 
In the ER-MP12hi20- subset one out of eight plated cells 
gave rise to primarily large macrophage colonies in re- 
sponse to M-CSF (Table 2), while in the ER-MP12+20+ 
subset one out of nine plated cells gave rise to primarily 
clusters and small colonies. In the ER-MP12-20hi bone 
marrow subset, which consists predominantly of monocytes 
(cf. Table l), an average of one out of two plated cells 
formed a small cluster of usually less than 5 cells, and 
occasionally a cluster of 15-20 cells.Taking into account the 
relative sizes of the sorted subsets in bone marrow, these 
data indicate that macrophage colony-forming cells reside 
in approximately equal numbers in both the ER-MP12hi20- 
and ER-MP12+20+ subsets. Macrophage cluster-forming 
cells are mainly present in the ER-MP12+20+ and ER- 
MP12-20hi bone marrow subsets. Together, our data show 
that (i) M-CSF-responsive macrophage precursors reside in 
the ER-MP12hi20-, ER-MP12+20+, and ER-MP12-20hi 
subsets and (ii) the proliferative potential of the M- 
CSF-responsive cells, as indicated by the sizes of the 
colonies or clusters formed, decreases with a concomitant 
increase in ER-MP20 and decrease in ER-MP12 Ag 
expression. 
3.3 The ER-MPUbO-, ER-MPlZ+20+ and 
ER-MP12-Wi bone marrow subsets differentially 
express the Mac-1 Ag 
The differences in cellular composition and proliferative 
potential of the ER-MP12hi20-, ER-MP12+20+ and ER- 
MP12-20hi bone marrow subsets suggested a difference in 
maturation stage between the macrophage precursors 
present in those subsets. To investigate this, we examined 
the expression of the macrophage maturation-related 
marker Mac-1 [lo, 111 within the three subsets. As shown 
in Fig. 3, all ER-MP12hi20- cells were Mac-1-negative/dull. 
In contrast, 40 +_ 5 %  (n = 3) of the ER-MP12+20+ bone 
marrow cells clearly expressed the Mac-1 Ag. This percent- 
age correlates closely with the total content of myeloid cells 
in this subset as determined by the morphological analysis 
(Table 1). Finally, virtually all ER-MP12-20hi cells were 
Mac-1-positive. This observation was in accordance with 
the morphological data which showed that this subset 
almost exclusively contains monocytes and some immature 
myeloid precursors, which are all Mac-1-positive [lo, 121. 
Thus, the increase in the proportion of Mac-1 positive cells 
and level of Ag expression observed from the ER- 
MP12hi20- to the ER-MP12-20hi subset supports an 
increase in maturity of the macrophage precursors present 
in those subsets. 
3.4 ER-MPUhi2Q- macrophage precursors successively 
express the ER-MPWU)+ and ER-MPl2-W’ 
phenotype during M-CSF-stimulated maturation 
in vitro 
So far, the data obtained in this study suggest that the three 
macrophage precursor subsets represent successive stages 
in a linear maturation pathway, implying that the progeny 
of the putatively least mature subset, i.e. ER-MP12hi20-, 
should pass through the other two phenotypes upon 
log fluorescence intensity 
Figure 3. Cell surface expression of Mac-1 Ag by ER-MP12hi20-, 
ER-MP12+20+, and ER-MP12-20h1 nucleated bone marrow cells. 
Cells were triple-labeled as described in Sect. 2.4 with MU70 
(Mac-1), ER-MP12 and ER-MP20 mAb. Mac-1 expression within 
the ER-MP12120 subsets was determined by flow-cytometric 
analysis. The staining profile of total bone marrow (TBM) is also 
given. The dotted lines represent negative control values. Results 
are from one representative experiment out of three. 
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MP12+20+ and ER-MP12-20hi phenotypes during M- 
CSF-stimulated maturation in v i m .  Under these condi- 
tions, ER-MP12-20- cells represent the final stage of 
macrophage development. The latter cells, however, are 
mature macrophages and do not represent the ER- 
MP12-20- subset found in normal mouse bone marrow. 
day 5 day 7 
macrophage maturation. To test this hypothesis directly, we 
sorted ER-MP12hi20- bone marrow cells and cultured the 
isolated cells in M-CSF-containing conditioned medium. 
After varying periods of culture the level of ER-MP12 and 
ER-MP20 Ag expression was determined. As a marker for 
mature macrophages, the expression of the ER-BMDM1 
Ag was also examined. This latter antigen is expressed at 
increasing levels upon maturation from the monocytic stage 
onwards [5] .  
At day 2 of M-CSF-stimulated culture of ER-MP12hi20- 
cells, about one third of the developing cells expressed both 
the ER-MP12 and the ER-MP20 antigens (Fig. 4A), sug- 
gesting that many, if not all, mononuclear phagocytes 
indeed pass through the ER-MP12+20+ stage upon in vitro 
maturation. The remaining ER-MP12+20- cells probably 
represented M-CSF-unresponsive cells from other hemo- 
poietic lineages still present at this time of culture. At day 5 
of culture, the cells had completely lost ER-MP12 antigen 
expression (Fig. 4A). Yet, 50-59 % ( n  = 2) of the cells 
expressed the ER-MP20 antigen at a high level, similar to 
that of ER-MP12-20hi monocytes in freshly isolated bone 
marrow (cf. Fig. 1). The ER-MP20-negative cells present 
after 5 days of culture represented mononuclear phago- 
cytes beyond the monocytic stage of development as (i) at 
this day of culture 26-34% of the cells expressed the 
mature macrophage marker ER-BMDMl (Fig. 4B) and (ii) 
the ER-MP20-negative cells showed a high level of auto- 
fluorescence (Fig. 4A, days 5 and 7) which is characteristic 
of more mature mononuclear phagocytes ([l l]  and unpub- 
lished observations). Upon final maturation into mature 
macrophages (day 7) the expression of the ER-MP20 
antigen was lost (Fig. 4A) and the large majority of the cells 
(66-75 %) had become ER-BMDM1-positive (Fig. 4B). 
In summary, these findings show that ER-MP12hi20- 
macrophage precursors successively express the ER- 
I day2 1 I day5 1 1 day7 
ERMPZO 
ERBMDMl ER.BMDM1 
Figure 4 .  Phenotypic development of ER-MP12”20- bone mar- 
row cells cultured in the presence of M-CSF. ER-MP12hi20- bone 
marrow cells were sorted and cultured in the presence of M- 
CSF-containingconditionedmedium. At days 2 , 5  and 7 of culture, 
the cells were collected and the expression of ER-MP12 and 
ER-MP20 antigens was determined in two-color flow-cytometric 
analysis (A). Negative control limits are shown in each dot plot 
(vertical and horizontal lines). In addition, the expression of the 
macrophage maturation marker ER-BMDM1 was determined in 
one-color analysis (B). Negative controls (thin lines) are shown in 
each histogram. Results are from one representative experiment 
out of two. 
4 Discussion 
In the present study we focused on the identification of 
different subpopulations of macrophage precursors in the 
bone marrow of the mouse.To this end, the reactivity of the 
anti-macrophage precursor mAb ER-MP12 and ER-MP20 
with bone marrow macrophage precursors was assessed in 
two-color flow cytometry. At least six phenotypically 
distinct bone marrow subsets can be discerned using these 
mAb. However, only three of these subsets, i.e. ER- 
MP12hi20-, ER-MP12+20+, and ER-MP12-20hi, gave rise 
to macrophage progeny after M-CSF-stimulated culture. 
Together these subsets comprise about 15 YO of nucleated 
bone marrow cells. 
All data presented in this study support the notion that 
these precursors reflect different, successive stages of 
macrophage development in the murine bone marrow. The 
first indication for the existence of a maturational differ- 
ence came from morphological analysis of the sorted 
subsets. The differential counts showed that potential 
macrophage precursor cell types, i. e. morphologically un- 
differentiated blasts, immature myeloid cells, and mono- 
cytes, were not evenly distributed among the ER-MP12hi- 
20-, ER-MP12+20+, and ER-MP12-20hi subsets. Morpho- 
logically undifferentiated blasts were concentrated in the 
ER-MP12hi20- and ER-MP12+20+ subsets, immature 
myeloid cells in the ER-MP12+20+ and ER-MP12-20h’ 
subsets, whereas monocytes were concentrated in the 
ER-MP12-20” subset, thus suggesting differences in matu- 
ration stage among these subsets. A second indication was 
obtained from the differences in macrophage colonyklus- 
ter-forming capacities of the subsets. ER-MP12hi20- cells 
formed the largest colonies and therefore are presumably 
the most immature cells. ER-MP12+20+ and ER- 
MP12-20hi cells formed predominantly large and small 
clusters, respectively, and thus, most likely represent 
subsequent stages. In the third place, the expression of the 
Mac-1 Ag, which is expressed relatively late during macro- 
phage maturation [lo, 111, follows the proposed matura- 
tion sequence of the precursor subsets.The Mac-1 Ag is not 
expressed in the ER-MP12hi20- subset, while about half of 
the ER-MP12+20+ subset and all cells in the ER-MP12-20h’ 
subset are Mac-1-positive. Finally, the most direct indica- 
tion for the existence of a maturation sequence came from 
the phenotypic development of the, putatively youngest, 
ER-MP12hi20- precursors during M-CSF-stimulated cul- 
ture.We found that the developing cells successively passed 
through ER-MP12+20+ and ER-MP12-20hi stages before 
final maturation into mature macrophages. Thus, the 
morphological data, the clonogenic data, the expression of 
Mac-1 and the phenotypic development during culture all 
indicate that the three phenotypically distinct M-CSF- 
responsive bone marrow macrophage precursor subsets 
most likely represent successive stages along a maturation 
pathway in the order ER-MP12hi20- + ER- 
MP12+20+ + ER-MP12-20hi. 
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Interestingly, macrophage colonies could be generated 
from both the ER-MP12”20- and ER-MP12+20+ bone 
marrow subsets. Expressed in absolute numbers, about half 
of all bone marrow macrophage colony-forming cells 
resided in the ER-MP12hi20- subset and the other half in 
the ER-MP12+2Of subset. MacVittie [13] reported for 
C57BL/6J mice an M-CFC frequency in bone marrow of 
approximately twice the frequency of GM-CFC.Thus, of all 
macrophage colonies formed in their study, about two 
thirds was derived from an M-CFC and one third from a 
GM-CFC. Combining these data with our observations on 
ER-MP12/20 expression by macrophage colony-forming 
cells, we speculate that the ER-MP12hi20- macrophage 
precursors, which form the largest colonies, represent the 
more immature GM-CFC and part of the M-CFC, while the 
colony-forming macrophage precursors in the ER- 
MP12+20+ subset might represent the majority of the 
M-CFC. 
Our data showed that the earliest M-CFC in the bone 
marrow are ER-MP12h’20-. Recently splenic M-CFC were 
found to express the ER-MP20 Ag at a high level and thus 
differ from bone marrow M-CFC, which are ER-MP20- or 
ER-MP20dlm [14]. It is unlikely that this difference in 
ER-MP20 expression reflects a maturational difference 
since the splenic ER-MP20h1 cells are, like the bone marrow 
ER-MP20- and ER-MP20dim cells, able to form large 
macrophage colonies in culture. Therefore, it will be 
interesting to study the ER-MP12 Ag expression of splenic 
M-CFC, as, in bone marrow, this is clearly related to 
colony-forming capacity. 
Both the differential counts and the macrophage precursor 
frequencies (cf. Tables 1 and 2) of the ER-MP12h120- and 
ER-MP12+20+ subsets indicate that these fractions do not 
solely contain precursors of the macrophage lineage. 
Morphological analysis of the subsets showed that precur- 
sors of the erythroid, lymphoid and granulocytic lineages 
are present in these subsets. In accordance with this 
observation, we recently reported that ER-MP12h120- bone 
marrow cells gave rise to both myeloid cells as well asTand 
B cells upon intravenous (i.v.) transfer into irradiated 
recipients [15]. Thus, although the ER-MP12h120- and 
ER-MP12+20+ bone marrow subsets are both highly 
enriched for macrophage precursors, additional cell surface 
markers are required to separate early macrophage precur- 
sors from other hemopoietic progenitors. 
A remarkable finding was that no macrophage colonies or 
clusters could be grown from ER-MP12med20- bone mar- 
row cells in M-CSF-stimulated culture, although we recent- 
ly reported that ER-MP12med20- bone marrow cells, upon 
i.v. transfer into irradiated recipients, were capable of both 
myeloid and T and B cell repopulation [15]. This apparent 
contradiction can be explained by the presence of more 
immature progenitors and multipotent stem cells within the 
ER-MP12med20- subset (J.C.M van der Loo et al. , manu- 
script in preparation). Such cells do not yet respond in 
culture to M-CSF alone. In vivo, however, the cells most 
likely meet the appropriate microenvironments and will 
eventually become sensitive to M-CSF and form mature 
macrophage progeny. 
To our knowledge , ER-MP12 and ER-MP20 are the first set 
of mAb described which positively identify discrete, suc- 
cessive macrophage precursor stages in the bone marrow of 
the mouse. Furthermore, as the ER-MP12”20- bone 
marrow subset was found to contain macrophage precur- 
sors as well as precursors of other lineages, it may be 
possible, using additional markers, to identify early branch 
points in hemopoiesis. 
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